Are you Dr. Zaloudek?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-1633Fax+1 415-353-1200
Summary
- Dr. Charles Zaloudek, MD is a board certified pathologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with UCSF Medical Center and Zuckerberg San Francisco General Hospital and Trauma Center.
Education & Training
- University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 1974 - 1975
- Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1971 - 1974
- Johns Hopkins University School of MedicineClass of 1971
Certifications & Licensure
- CA State Medical License 1973 - 2025
- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 23 citationsCytoplasmic Pattern p53 Immunoexpression in Pelvic and Endometrial Carcinomas With TP53 Mutation Involving Nuclear Localization Domains: An Uncommon But Potential Diag...Joseph T. Rabban, Karuna Garg, Nicholas R. Ladwig, Charles Zaloudek, W. Patrick Devine
The American Journal of Surgical Pathology. 2021-04-23 - 14 citationsCorded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.Nicholas R. Ladwig, Sarah E. Umetsu, Charles Zaloudek, Joseph T. Rabban, Karuna Garg
International Journal of Gynecological Pathology. 2021-03-01 - 3 citationsComplete Response to PD-1 Inhibition in an Adolescent With Relapsed Clear Cell Adenocarcinoma of the Cervix Predicted by Neoepitope Burden and APOBEC SignatureAnya Levinson, Alex G. Lee, Henry J Martell, Marcus R. Breese, Charles Zaloudek
JCO Precision Oncology. 2020-11-02